GSK Pharma Chief Exits After Losing CEO Spot

Source: MarketWatch

Jan 19, 2017

GlaxoSmithKline's pharmaceuticals chief Abbas Hussain will be leaving the company after not being chosen to succeed outgoing Chief Executive Andrew Witty.

Hussain, who spent eight years at GSK, was one of a few top Glaxo execs beaten by former consumer healthcare boss Emma Walmsley for the CEO spot.

Hussain will be replaced by AstraZeneca executive Luke Miels -- Walmsley's first external appointment as CEO-designate.

Read the Marketwatch coverage

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments